Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Venus Remedies Ltd banner

Venus Remedies Ltd
NSE:VENUSREM

Watchlist Manager
Venus Remedies Ltd Logo
Venus Remedies Ltd
NSE:VENUSREM
Watchlist
Price: 746 INR -1.76% Market Closed
Market Cap: ₹10B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

VENUSREM Price Targets Summary
Venus Remedies Ltd

Wall Street analysts forecast VENUSREM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VENUSREM is 332.52 INR with a low forecast of 329.26 INR and a high forecast of 342.3 INR.

VENUSREM Lowest Forecast
Wall Street Target
329.26 INR
-56% Downside
VENUSREM Average Forecast
Wall Street Target
332.52 INR
-55% Downside
VENUSREM Highest Forecast
Wall Street Target
342.3 INR
-54% Downside
Lowest
Price Target
329.26 INR
56% Downside
Average
Price Target
332.52 INR
55% Downside
Highest
Price Target
342.3 INR
54% Downside
Venus Remedies Ltd Competitors:
Price Targets
I
IMRX
Immuneering Corp
246% Upside
SONO
Sonos Inc
27% Upside
I
IMRX
Immuneering Corp
246% Upside
SONO
Sonos Inc
27% Upside

Revenue
Forecast

4% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
4% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 13 years the compound annual growth rate for Venus Remedies Ltd's revenue is 4%. The projected CAGR for the next 2 years is 15%.

What are analyst estimates?

Operating Income
Forecast

-5% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-5% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Venus Remedies Ltd

Net Income
Forecast

0% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss
0% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss

For the last 13 years the compound annual growth rate for Venus Remedies Ltd's net income is 0%. The projected CAGR for the next 2 years is 10%.

What are analyst estimates?

See Also

Summary
VENUSREM intrinsic value, competitors valuation, and company profile.
DCF Valuation
VENUSREM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VENUSREM stock valuation using valuation multiples.
Wall Street Estimates
VENUSREM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VENUSREM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VENUSREM's stock price target?
Price Target
332.52 INR

According to Wall Street analysts, the average 1-year price target for VENUSREM is 332.52 INR with a low forecast of 329.26 INR and a high forecast of 342.3 INR.

What is Venus Remedies Ltd's Revenue forecast?
Projected CAGR
15%

For the last 13 years the compound annual growth rate for Venus Remedies Ltd's revenue is 4%. The projected CAGR for the next 2 years is 15%.

What is Venus Remedies Ltd's Net Income forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for Venus Remedies Ltd's net income is 0%. The projected CAGR for the next 2 years is 10%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 319,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.